Hamamatsu Photonics received FDA 510(k) clearance for its NanoZoomer S20MD and S540MD slide scanner systems, expanding digital pathology options for clinical labs to include compact benchtop and high-throughput workflows.
From clot formation to functional and antigen testing, fibrinogen measurement helps laboratories evaluate bleeding disorders, monitor critical illness, and support patient care.
BillionToOne has launched Northstar Origin, a liquid biopsy add-on that predicts cancer tissue of origin from cell-free DNA, and expands its genomic profiling panel to 102 genes.
A recent NYU study finds 68.6% of US adults now access lab results via online portals before clinician review, with comprehension varying by digital literacy and patient-centered communication.
Kumamoto University researchers have developed a blood test that analyzes nucleosome structures in cell-free DNA to detect breast cancer recurrence.
